These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 15663763

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Gene polymorphism association studies in dialysis: cardiovascular disease.
    Rao M, Jaber BL, Balakrishnan VS, DialGene Consortium.
    Semin Dial; 2005; 18(3):217-25. PubMed ID: 15934969
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
    Buraczynska M, Ksiazek P, Drop A, Zaluska W, Spasiewicz D, Ksiazek A.
    Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Platelet GP IIIA polymorphism HPA-1 (PLA1/2) is associated with hypertension as the primary cause for end-stage renal disease in hemodialysis patients from Greece.
    Chiras T, Papadakis ED, Katopodi A, Chatzianesti E, Fourtounas K, Papakonstantinou S, Theodoropoulos I, Dakouras A, Zerefos N, Valis D, Tzanatos-Exarchou H.
    In Vivo; 2009 Apr; 23(1):177-81. PubMed ID: 19368146
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.
    Akman B, Tarhan C, Arat Z, Sezer S, Ozdemir FN.
    Ren Fail; 2009 Apr; 31(3):196-200. PubMed ID: 19288324
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of non-HLA genetic variants in end-stage renal disease.
    Ranganath P, Tripathi G, Sharma RK, Sankhwar SN, Agrawal S.
    Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
    [Abstract] [Full Text] [Related]

  • 16. [The Human Genome Project, genetic viability and genetic epidemiology].
    Hagymási K, Tulassay Z.
    Orv Hetil; 2005 Dec 18; 146(51):2575-80. PubMed ID: 16468611
    [Abstract] [Full Text] [Related]

  • 17. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
    Buraczynska M, Swatowski A, Buraczynska K, Dragan M, Ksiazek A.
    Clin Sci (Lond); 2009 Jan 18; 116(1):81-6. PubMed ID: 18518860
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human platelet antigens polymorphisms and susceptibility of thrombosis in hemodialysis patients.
    Gorgi Y, Sfar I, Ben Aabdallah T, Aouadi H, Abderrahim E, Bardi R, Jendoubi-Ayed S, Ayed K.
    Hemodial Int; 2008 Jul 18; 12(3):331-5. PubMed ID: 18638089
    [Abstract] [Full Text] [Related]

  • 20. Health-related disparities: influence of environmental factors.
    Olden K, White SL.
    Med Clin North Am; 2005 Jul 18; 89(4):721-38. PubMed ID: 15925646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.